Filing Details
- Accession Number:
- 0001209191-22-061903
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-19 16:21:25
- Reporting Period:
- 2022-12-15
- Accepted Time:
- 2022-12-19 16:21:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1419041 | Forte Biosciences Inc. | FBRX | Pharmaceutical Preparations (2834) | 261243872 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612842 | A. Paul Wagner | C/O Forte Biosciences, Inc. 3060 Pegasus Park Dr., Bldg 6 Dallas TX 75247 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-15 | 55,976 | $1.03 | 1,335,025 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-12-16 | 44,024 | $1.07 | 1,379,049 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 55,976 shares purchased in the price range of $1.00 to $1.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Represents the weighted average share price of an aggregate total of 44,024 shares purchased in the price range of $1.03 to $1.09 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.